JP2005521721A5 - - Google Patents

Download PDF

Info

Publication number
JP2005521721A5
JP2005521721A5 JP2003580271A JP2003580271A JP2005521721A5 JP 2005521721 A5 JP2005521721 A5 JP 2005521721A5 JP 2003580271 A JP2003580271 A JP 2003580271A JP 2003580271 A JP2003580271 A JP 2003580271A JP 2005521721 A5 JP2005521721 A5 JP 2005521721A5
Authority
JP
Japan
Prior art keywords
phenyl
amino
diphenylethyl
methyl
propoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2003580271A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005521721A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/009278 external-priority patent/WO2003082802A1/en
Publication of JP2005521721A publication Critical patent/JP2005521721A/ja
Publication of JP2005521721A5 publication Critical patent/JP2005521721A5/ja
Withdrawn legal-status Critical Current

Links

JP2003580271A 2002-03-27 2003-03-26 酸およびエステル化合物ならびにその使用方法 Withdrawn JP2005521721A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36842602P 2002-03-27 2002-03-27
PCT/US2003/009278 WO2003082802A1 (en) 2002-03-27 2003-03-26 Acid and ester compounds and methods of using the same

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2009235241A Division JP2010047582A (ja) 2002-03-27 2009-10-09 酸およびエステル化合物ならびにその使用方法

Publications (2)

Publication Number Publication Date
JP2005521721A JP2005521721A (ja) 2005-07-21
JP2005521721A5 true JP2005521721A5 (https=) 2006-05-18

Family

ID=28675490

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2003580271A Withdrawn JP2005521721A (ja) 2002-03-27 2003-03-26 酸およびエステル化合物ならびにその使用方法
JP2009235241A Pending JP2010047582A (ja) 2002-03-27 2009-10-09 酸およびエステル化合物ならびにその使用方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2009235241A Pending JP2010047582A (ja) 2002-03-27 2009-10-09 酸およびエステル化合物ならびにその使用方法

Country Status (5)

Country Link
US (1) US7560586B2 (https=)
EP (1) EP1487776A4 (https=)
JP (2) JP2005521721A (https=)
AU (1) AU2003222083A1 (https=)
WO (1) WO2003082802A1 (https=)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003220558A1 (en) 2002-03-27 2004-06-03 Smithkline Beecham Corporation Amide compounds and methods of using the same
EP1490047B1 (en) 2002-03-27 2009-12-30 SmithKline Beecham Corporation Certain pharmaceutically useful substituted aminoalkyl heterocycles
EP1575495A4 (en) * 2002-03-27 2009-12-02 Smithkline Beecham Corp COMPOUNDS AND METHODS
US20060189693A1 (en) * 2003-07-22 2006-08-24 Barone Frank C Methods of treatment with lxr agonists
WO2005077122A2 (en) * 2004-02-11 2005-08-25 Irm Llc Compounds and compositions as lxr modulators
FR2869904B1 (fr) 2004-05-07 2006-07-28 Fournier S A Sa Lab Modulateurs des recepteurs lxr
US7989179B2 (en) * 2005-06-28 2011-08-02 Daiichi Sankyo Company, Limited LXR ligand testing method
US8993628B2 (en) * 2007-02-23 2015-03-31 City Of Hope Synthetic ligands selective for LXRβ over LXRα, identification and methods of use thereof
WO2012033353A2 (ko) 2010-09-07 2012-03-15 서울대학교 산학협력단 세스터터핀 화합물 및 이들 물질의 용도
AU2013302861A1 (en) * 2012-08-13 2015-03-05 The Rockefeller University Treatment and diagnosis of melanoma
WO2015106164A1 (en) * 2014-01-10 2015-07-16 Rgenix, Inc. Lxr agonists and uses thereof
EP3402477A4 (en) 2016-01-11 2019-08-21 The Rockefeller University METHOD FOR THE TREATMENT OF DISEASES RELATED TO MYELOID-DERIVED SUPPRESSOR CELLS
EP3589280B1 (en) * 2017-03-03 2024-02-07 Inspirna, Inc. Formulations with improved stability
TWI683808B (zh) 2017-07-18 2020-02-01 德商菲尼克斯 Fxr有限責任公司 含有胺或(硫)醯胺之lxr調節劑
CA3078981A1 (en) 2017-11-21 2019-05-31 Rgenix, Inc. Polymorphs and uses thereof
TWI748194B (zh) 2018-06-28 2021-12-01 德商菲尼克斯 Fxr有限責任公司 含有雙環核心部分之新穎lxr調節劑
EP3999055A1 (en) 2019-07-15 2022-05-25 Novartis AG Methods for treating meibomian gland dysfunction with liver x receptor agonists
TWI888447B (zh) 2019-12-13 2025-07-01 美商因思博納公司 金屬鹽及其用途
CN112079732B (zh) * 2020-09-22 2021-10-08 湖南大学 一种4-烃基仲胺基-2-丁醇类化合物的合成路线

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US72868A (en) * 1867-12-31 Lewis leigh
US699659A (en) * 1900-08-10 1902-05-13 Michael R Colvin Gas stop-cock.
ES444144A1 (es) 1975-01-14 1977-08-16 Hoechst Ag Un procedimiento para la preparacion de un acido 6,11-dihi- dro-11-oxo-dibenz (b, e) oxepin-alcanoico.
DE3889545T2 (de) * 1987-10-20 1994-10-13 Otsuka Pharma Co Ltd Phenylcarbonsäure-abkömmlinge.
US6499762B1 (en) * 1995-06-05 2002-12-31 Adorno/Rogers Technology, Inc. Frame support apparatus and coupling device for use with an ambulatory system and method of fabrication thereof
JP3676074B2 (ja) * 1997-03-14 2005-07-27 Tdk株式会社 ホットメルト材およびラミネート体とその製造方法
US20030153541A1 (en) * 1997-10-31 2003-08-14 Robert Dudley Novel anticholesterol compositions and method for using same
DE19826414A1 (de) * 1998-06-16 1999-12-23 Coronet Werke Gmbh Verfahren zum Verbinden, Markieren und struktuellem Verändern von Monofilen
FR2811973A1 (fr) * 2000-07-18 2002-01-25 Windmoeller & Hoelscher Agencement de grue pour le transport de rouleaux de bandes
WO2002024632A2 (en) * 2000-09-18 2002-03-28 Glaxo Group Limited Substituted aminopropoxyaryl derivatives useful as agonists for lxr
US20030229062A1 (en) * 2001-12-07 2003-12-11 The Regents Of The University Of California Treatments for age-related macular degeneration (AMD)
WO2003049685A2 (en) * 2001-12-07 2003-06-19 The Regents Of The University Of California Treatment for age-related macular degeneration
US7470659B2 (en) * 2001-12-07 2008-12-30 The Regents Of The University Of California Methods to increase reverse cholesterol transport in the retinal pigment epithelium (RPE) and Bruch's membrane (BM)
AU2003220558A1 (en) * 2002-03-27 2004-06-03 Smithkline Beecham Corporation Amide compounds and methods of using the same
US20050171084A1 (en) * 2002-03-27 2005-08-04 Cairns William J. Methods of treatment with lxr modulators
EP1575495A4 (en) * 2002-03-27 2009-12-02 Smithkline Beecham Corp COMPOUNDS AND METHODS
EP1490047B1 (en) 2002-03-27 2009-12-30 SmithKline Beecham Corporation Certain pharmaceutically useful substituted aminoalkyl heterocycles
WO2004058175A2 (en) * 2002-12-23 2004-07-15 Irm Llc Novel use of liver x receptor agonists
GB0230177D0 (en) 2002-12-24 2003-02-05 Karobio Ab LXR beta crystal
EP1635832A2 (en) 2003-06-06 2006-03-22 Merck & Co., Inc. Combination therapy for the treatment of diabetes
EP1635773A2 (en) 2003-06-06 2006-03-22 Merck & Co., Inc. (a New Jersey corp.) Combination therapy for the treatment of hypertension
US20060189693A1 (en) 2003-07-22 2006-08-24 Barone Frank C Methods of treatment with lxr agonists
JP2007500158A (ja) 2003-07-28 2007-01-11 グラクソ グループ リミテッド Lxrアゴニストを用いる炎症性腸疾患の治療方法
WO2005055998A1 (en) 2003-12-04 2005-06-23 Smithkline Beecham Corporation Methods of treatment with lxr agonists
AU2004298486A1 (en) * 2003-12-12 2005-06-30 Wyeth Quinolines useful in treating cardiovascular disease
US20060020036A1 (en) 2004-06-24 2006-01-26 Luc Van Rompaey Methods and compositions to promote bone homestasis
WO2006004030A1 (ja) 2004-07-02 2006-01-12 Sankyo Company, Limited 組織因子産生抑制剤

Similar Documents

Publication Publication Date Title
JP2005521721A5 (https=)
JP2007502806A5 (https=)
JP2004533450A5 (https=)
JP4809764B2 (ja) アンドロゲン受容体モジュレーターとして有用なプロピオンアミド誘導体
RU2006107653A (ru) Связующее вспомогательное вещество и приготовленная на его основе таблетка в форме капли
JP2005522476A5 (https=)
JP2005502635A5 (https=)
JP2005527618A5 (https=)
RU2494089C2 (ru) Соединения, представляющие собой стиролильные производные, для лечения офтальмических заболеваний и расстройств
JP2013541514A5 (https=)
JP2004529174A5 (https=)
JP2008523126A5 (https=)
JP2004513076A5 (https=)
JP2004507465A5 (https=)
JP2005536475A5 (https=)
JP2002508347A5 (https=)
JP2004511462A5 (https=)
JP2005528348A5 (https=)
JP2004532229A5 (https=)
DE02735262T1 (de) Schilddrüsenhormon-rezeptor-antagonisten zur behandlung von herzerkrankungen & metabolischen störungen
JP2005524605A5 (https=)
JP2002513793A5 (https=)
JP2005539045A5 (https=)
JP2002531548A5 (https=)
JP2008537547A5 (https=)